Last reviewed · How we verify
Hb SS disease
Approved treatments
- Hydroxycarbamide · University of Birmingham
- Siklos · Theravia
- Xromi · Nova Laboratories Limited
- Hydroxycarbamid · Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Hb SS disease patent landscape — cliff calendar, originator estates, attackable patents
- Hb SS disease treatment landscape brief
- Hb SS disease treatment updates RSS
Frequently asked questions about Hb SS disease
What drugs treat Hb SS disease?
Tracked treatments include Hydroxycarbamide, Siklos, Xromi, Hydroxycarbamid.
What is the treatment for Hb SS disease?
Standard treatment for Hb SS disease includes Hydroxycarbamide, Siklos, Xromi, Hydroxycarbamid. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Hb SS disease patent cliff · Hb SS disease CI report
- Treatment: Hydroxycarbamide · University of Birmingham
- Treatment: Siklos · Theravia
- Treatment: Xromi · Nova Laboratories Limited
- Treatment: Hydroxycarbamid · Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing